Tag: Cancer treatment
Ascentage Pharma showcases novel drug candidates at AACR 2024
Ascentage Pharma (6855.HK), a prominent global biopharmaceutical firm, recently unveiled the latest preclinical study results for its innovative drug candidates at the American Association of ... Read More
Genmab to acquire ProfoundBio in $1.8bn deal to enhance cancer treatment
In a landmark move within the biotechnology sector, Genmab A/S (Nasdaq: GMAB) and ProfoundBio, Inc. have announced a definitive agreement under which Genmab will acquire ... Read More
Bristol Myers Squibb announces success of KRAZATI in Phase 3 KRYSTAL-12 study
Bristol Myers Squibb (NYSE: BMY) has reached a pivotal milestone in the treatment of non-small cell lung cancer (NSCLC) with its announcement regarding the KRYSTAL-12 ... Read More
Kate Middleton announces preventative chemotherapy following cancer discovery
Kate Middleton, the Princess of Wales, has publicly disclosed her ongoing preventative chemotherapy treatment after a major abdominal surgery in January unveiled the presence of ... Read More
AstraZeneca to acquire Fusion Pharmaceuticals to boost cancer radioconjugate development
In a strategic move to revolutionize cancer treatment, AstraZeneca has announced its definitive agreement to acquire Fusion Pharmaceuticals Inc., a pioneer in the development of ... Read More
FDA approves BeiGene’s TEVIMBRA for esophageal cancer treatment
In a notable advancement in the oncology sector, BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a globally recognized oncology company, has received approval from ... Read More
GE HealthCare, Elekta join forces to enhance cancer treatment in India
GE HealthCare, a prominent global player in the medical technology and diagnostics sector, is broadening its partnership with Elekta, a leading name in radiation therapy, ... Read More
Yashoda Hospital, Elekta introduce Unity MR Linac for cancer treatment
Yashoda Hospital, in partnership with Elekta, a Swedish developer of precision radiation therapy, has introduced the latter’s Unity MR Linac system in India, marking a ... Read More
Massive Bio, The Oncology Institute partner to revolutionize cancer treatment
Massive Bio, a healthcare technology company specializing in personalized treatment solutions for cancer patients, has announced a non-exclusive partnership with The Oncology Institute (TOI), a ... Read More
Lupin, Enzene Biosciences to launch cancer drug Cetuximab biosimilar in India
Lupin, an Indian pharmaceutical company, has announced a strategic collaboration with Enzene Biosciences, a subsidiary of Alkem Laboratories, to introduce Cetuximab in India. Cetuximab is ... Read More